Eris Lifesciences was up 1.18% to Rs 406.7 at 10:05 IST on the BSE after net profit rose 18% to Rs 84.05 crore on 10% rise in net sales to Rs 271.89 crore in Q1 June 2019 over Q1 June 2018.
The result was announced on Saturday, 27 July 2019.
Meanwhile, the S&P BSE Sensex was up by 75.79 points or 0.19% to 37,807.83.
On the BSE, 2717 shares were traded in the counter so far compared with average daily volumes of 2133 shares in the past two weeks. The stock had hit a high of Rs 425.1 and a low of Rs 400.55. The stock hit a 52-week high of Rs 798.8 on 27 August 2018 and a 52-week low of Rs 390 on 24 July 2019.
The company's consolidated earnings before interest tax depreciation and amortization (EBITDA) increased 18% to Rs 104.5 crore in Q1 June 2019 over Q1 June 2018.
The consolidated EBITDA margin rose to 38.1% from 35.3% in Q1 June 2019 over Q1 June 2018.
Eris Lifesciences is engaged in developing, manufacturing and commercializing branded pharmaceutical products in select therapeutic areas within the chronic and acute categories of the Indian Pharmaceutical Market.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app